Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Authors
Keywords
-
Journal
Nature Cancer
Volume 4, Issue 5, Pages 699-715
Publisher
Springer Science and Business Media LLC
Online
2023-04-11
DOI
10.1038/s43018-023-00539-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
- (2022) Martin K. Bakht et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
- (2022) Xiaodong Lu et al. NATURE GENETICS
- PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
- (2022) Vivek Narayan et al. NATURE MEDICINE
- Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
- (2022) Fanying Tang et al. SCIENCE
- [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
- (2021) Michael S Hofman et al. LANCET
- Transcriptional mediators of treatment resistance in lethal prostate cancer
- (2021) Meng Xiao He et al. NATURE MEDICINE
- Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
- (2021) Lauren Brady et al. Nature Communications
- Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
- (2021) Sylvan C. Baca et al. Nature Communications
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility
- (2021) Claudia Giambartolomei et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapy
- (2020) Fadi Khreish et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate cancer reactivates developmental epigenomic programs during metastatic progression
- (2020) Mark M. Pomerantz et al. NATURE GENETICS
- Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
- (2020) Andrea K. Miyahira et al. PROSTATE
- 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy
- (2020) Gaurav Malviya et al. EJNMMI Research
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
- (2019) Mariya Gusman et al. RADIOGRAPHICS
- The role of lineage plasticity in prostate cancer therapy resistance
- (2019) Himisha Beltran et al. CLINICAL CANCER RESEARCH
- Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
- (2019) Alec Paschalis et al. EUROPEAN UROLOGY
- Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer
- (2019) Irena Saarinen et al. EJNMMI Research
- Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for FDG imaging of PSMA-suppressed tumors
- (2019) Martin K. Bakht et al. JOURNAL OF NUCLEAR MEDICINE
- Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
- (2018) Zhong Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient derived organoids to model rare prostate cancer phenotypes
- (2018) Loredana Puca et al. Nature Communications
- Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
- (2018) Rongbin Zheng et al. NUCLEIC ACIDS RESEARCH
- BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud
- (2018) Denis Torre et al. Cell Systems
- Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
- (2018) Martin K Bakht et al. ENDOCRINE-RELATED CANCER
- TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
- (2017) Ken J Kron et al. NATURE GENETICS
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
- (2015) Himisha Beltran et al. JAMA Oncology
- Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
- (2015) H. Ross-Adams et al. EBioMedicine
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
- (2014) Qilai Huang et al. NATURE GENETICS
- Prostate-Specific Membrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal Prostate Cancer
- (2013) J. L. Kasperzyk et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- RSeQC: quality control of RNA-seq experiments
- (2012) Liguo Wang et al. BIOINFORMATICS
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
- (2011) H. Okudaira et al. JOURNAL OF NUCLEAR MEDICINE
- A public genome-scale lentiviral expression library of human ORFs
- (2011) Xiaoping Yang et al. NATURE METHODS
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens
- (2009) John D. Norris et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search